To evaluate the role of cyclic guanosine monophosphate (cGMP) in the vascular and renal action of atrial natriuretic peptide (ANP), we compared the effects of atriopeptins (APs) on cGMP accumulation in cultured cells from rat mesenteric vascular smooth muscle (VSM), glomerular mesangium (GM) and renal papillary collecting tubule (RPCT), and also evaluated the relationship between renal sodium or water excretion and urinary cGMP in AP-infused rats. Both AP I and AP III increased intracellular cGMP levels dose-dependently in all types of cells, while they did not affect intracellular cAMP levels or prostaglandin synthesis.
been shown to activate particulate guanylate cyclase and raises cyclic guanosine 3', 5'-monophosphate (cGMP) levels in target cells. ANP increases cGMP levels in various tissues including vasculature, adrenal gland and kidney, and in cultures of vascular endothelial or smooth muscle cells, renal tubules and glomerular mesangium (Hamet et al. 1984 Sato et al. 1986b ; Stokes et al. 1986) . It is well known that ANP selectively dilates renal artery (Oshima et al. 1984 ), and we have previously reported that the stimulatory effect of atriopeptin (AP) III on intracellular cGMP levels was greater in cultured vascular smooth muscle (VSM) cells from renal artery than those from mesenteric artery (Sato et al. 1986b ). Although these findings support the hypothesis that cGMP is a second messenger of the ANP action, the exact role of cGMP in these target cells or tissues remains to be clarified.
Recently, the studies with autoradiographic localization of binding sites for ANP demonstrated that the renal glomeruli and the inner medulla (papilla) as well as small arteries are the major binding sites of ANP (Von Schroeder et al. 1985 ; Chai et al. 1986 ; Kimura et al. 1986 ). Thus, the purporse of the present study is to compare the effects of ANP on cGMP accumulation in cultured cells from rat glomerular mesangium (GM), renal papillary collecting tubule (RPCT) and mesenteric VSM. We also examined the relationship between renal sodium or water excretion and urinary cGMP in ANP-infused rats to evaluate the role of cGMP in the renal action of ANP. We used both APs I and III to determine the functional relationship between cGMP and biological activites, since they have been shown to have different potency in producing renal vasodilation and natriuresis (Wakitani et al. 1985) . Preliminary results of portions of this study were presented at the 11th Scientific Meeting of the International Society of Hypertension, Heidelberg, Federal Republic of Germany, September, 1986, and published in its proceeding (Sato et al. 1986a ).
MATERIALS AND METHODS

Materials
Minimum essential medium (MEM), Hank's Balance Salt Solution, RPMI 1640, penicillin-streptomycin, and trypsin-EDTA were purchased from Gibco Laboratories (Grand Island, NY, USA). Collagenase (Type IV), N-2-hydroxyethylpiperazine-N'-2-ethanesulfaosd acid (HEPES) and 3-isobutyl-1-methylxanthine (IBMX) were purchased from Sigma Chemical (St. Louis, M0, USA), fetal bovine serum from MA Bioproduct (Walkersville, MD, USA), and ITS Premix from Collaborative Research (Lexington, MA, USA). AP I and AP III were obtained from Peninsula Laboratories (Belmost, CA, USA). Twelve-well culture dishes were purchased from Costar (Cambridge, MA, USA) and 24-well culture dishes from Nunc (Copenhagen, Denmark). Radioimmunoassay kits for CAMP and cGMP were purchased from Yamasa Shoyu (Choshi), and 3H-PGE2 and 3H-6-keto-PGFIa from Amersham (Tokyo). Antiserum for PGE2 was purchased from Pasteur Institut (Paris, France) and that for 6-keto-PGFIa was a kind gift from Dr. Michael J. Dunn, Cleveland, OH, USA.
Isolation and culture of cells VSM cells of mesenteric artery and RPCT cells were isolated and cultured from 150-200 g Sprague-Dawley rats as previously described (Sato and Dunn 1986 ; Sato et al. 1986b) . VSM cells at pasgage levels 3-9 and primary RPCT cells on days 4 or 5 of culture were used for experiments. GM cells were isolated simultaneously with RPCT cells from renal cortex of Sprague-Dawley rats according to the methods as previously described (Scharschmidt and Dunn 1983 ; Sato and Dunn 1984) with some modifications. After the glomeruli were prepared using 106-and 75-,uM sieves, they were placed in Hank's Balance Salt Solution without calcium and magnesium containing 750 U/ml collagenase (Type IV) with the antibiotic-antimycotic (1:100). The glomeruli were incubated for 30-45 min at 3TC in 5% C02-95% air with gentle agitation every 5 min. After the glomeruli were examined under a phase-contrast microscopy to determine whether the glomeruli were sufficiently digested, the glomeruli were 3 times washed with RPMI 1640 and finally resuspended in RPMI 1640 buffered with 15 mM HEPES, supplemented with 15% fetal bovine serum, ITS Premix (insulin: 5 u g/ml, transferrin : 5 jig/ml, selenium : 5 ng/ml) and penicillinstreptmycin (1:100). GM cells grew and predominated around days 10-15, and subculture was performed by using 0.25% trypsin-EDTA. GM cells were characterized by their typical morphology under both phase-contrast and electron microscopy. Experiments were performed on days 14-16 of the first subculture just before the cells reached confluency.
Determination of cGMP accumulation in cultured cells
All experiments with cultured cells were conducted at least in triplicate using 12-well culture dishes for VSM cells and GM cells or 24-well dishes for RPCT cells. Before incubation, cells were rinsed three times with 0.6 ml (or 0.4 ml for RPCT cells) MEM. Cells were incubated with AP I or AP III in 0.6 ml MEM in the presence of the phosphodiesterase inhibitor IBMX, 0.5 mM, for 5 min at 3TC in an atmosphere of 5% C02-95% air. In experiments with RPCT cells, MEM was made to 900 mosmol by the addition of NaCI and urea, 1:1 equiosmolar ratio (Sato and Dunn 1986 ). Experiments were terminated by removal of media, followed immediately by addition of 0.3 ml (or 0.2 ml for RPCT cells) of 0.1 N HC1. Cells were exposed to the HCl solution for 1 hr, intracellular cyclic nucleotides were extracted into the HC1 fraction, and part of the cellular protein was precipitated and left on the bottom of the culture dishes (Sato and Dunn 1986; Sato et al. 1986b ).
Effects of bolus injection of APs
Four male Sprague-Dawley rats weighing 200-250 g were subjected to this series of experiments which allowed a quantitative bioassay of ANP activities as previously described (Matsui et al. 1987 ). In rats under anesthesia with sodium pentobarbital, 0.6-0.8 ml of 10% mannitol in 0.9% saline was administered into the juglar vein and was continuously infused at a rate of 4.0 ml/hr by a syringe pump. Followiog equilibration of 45-60 min, experiments were started, when the urine flow rate increased to 50-75p1/min. All test samples with a volume of 100,1 were directly injected into the juglar vein via a small polyethylene tube connected to a three-way apparatus followed by a wash injection of about 30 p 1 of 0.9% saline. APs were dissolved in 0.9% saline containing 0.03% acetic acid. A vehicle alone as a control, 520 or 1040 ng of AP I and 640 ng of AP III were administered alternatively but the order of injection of APs was randomely chosen. Immediately after the injection, urine was collected for 10 min. Urine volumes were determined by weighing, and urinary sodium and potassium concentrations were measured by flamephotometry (Hitachi Flame Photometer 205 D, Hitachi, Ibaragi).
Assays
Radioimmunoassay of cGMP and cAMP were done in duplicate after succinylation using HC1 fraction or urine samples (Sato et al. 1986b ). PGE2 and 6-keto-PGFIa were measured by radioimmunoassay of the extracellular media using antisera as previously described (Sato and Dunn 1986; Sato et al. 1986b ). Cellular protein was measured on the precipitate in the culture dish and in 0.1 N HCl solution as previously described (Sate and Dunn 1986) by the methods of Lowry et al. (1951) .
Statistics
Values are expressed as means +s.E. The statistical significance was evaluated at the 95% confidence level using oneway analysis of variance or Student's t-test for unpaired observations.
RESULTS
Basal levels of intracellular cAMP, cGMP and psostaglandin (PG) in VSM cells, GM cells and RPCT cells were summarized in Table 1 . Basal cGMP levels were the highest in As shown in Fig. 4 , bolus injection of AP III (640 ng) induced a significant increase in urine volume, urinary sodium, potassium and cGMP excretion in anesthetized rats. 1040 ng of AP I also induced similar, but less potent effects on these parameters, while 520 ng of AP I failed to induce any significant changes. As previously reported (Matsui et al. 1987) , there was no obvious tachyphylaxis after the repeated injections of APs. There were positive relationships between AP-induced changes in urinary cGMP excretion and urine volume (r=0.581, p < 0.05) or urinary sodium excretion (r=0.536, p <0.05) (Fig. 5a and b) . 
DISCUSSION
We have previously reported that the stimulatory effect of AP III on intracellular cGMP levels was greater in cultured VSM cells from renal artery than in those from mesenteric artery (Sate et al. 1986b ). In the present study, we demonstrated that GM cells generated much more cGMP than VSM cells from mesenteric artery and RPCT cells in basal condition and in response to APs, while VSM cells were most sensitive to APs, exhibiting a threshold concentration 10-100 times lower than that necessary to produce a rise in cGMP levels in either GM or RPCT cells. These results in cultured cells are consistent with previous observations in isolated tubules or glomeruli on the stimulatory sites of ANP on cGMP synthesis in the kidney. Tremblay et al, (1985) clearly demonstrated that the most important target sites for ANP to stimulate cGMP levels in the kidney were glomeruli, and, to a lesser extent, the distal part of the nephron, but not the proximal tubules. The accumulation of cGMP in response to ANP correlated Stokes et al. 1986 ). Such a close relationship between ANP and cGMP has also been found in vivo. When atrial extracts or synthetic ANP were infused into rats or in man, plasma cGMP levels and urinary excretion of cGMP markedly rose (Hamet et al. 1984 ; Gerzer et al. 1985) . Furthermore, concomitant increase in plasma ANP and cGMP has been observed in normal volunteers during saline infusion (Weil et al. 1985) . In the present study, we also found that the bolus injection of AP I or AP III induced a marked rise in urinary cGMP levels in anesthetized rats, and that there were significant correlations between increases in urine flow or urinary sodium excretion and that of cGMP. In addition, both in cultured vascular and renal cells and in AP-injected rats, we found that 24 amino acid AP III was much more potent than AP I, which lacks the C-terminal Phe-Arg, to increase cGMP levels and to induce diuresis and natriuresis in the kidney. Since the previous reports indicated that AP III was biologically more active than AP I to induce vascular relaxation and natriuresis in anesthetized rats (Wakitani et al. 1985) , such a similar quantitative difference between the cGMP response to AP I and to AP III further supports the hypothesis that cGMP mediates the ANP action. Although the role of cGMP as a mediator of vasodila-Lion has been elusive, recent studies with rat thoracic aorta showed that relaxation in response to AP II was closely correlated in a time-and concentration-dependent manner with increases in cGMP concentrations and activation of cGMP-dependent protein kinase (Fiscus et al. 1985) . So far, we have reported that the vasodilatory action of ANP may be most responsible in producing natriuresis in ANP-infused dogs ) or in preventing hypertension induced by chronic infusion of norepinephrine or angiotensin II in rats (Yasujima et al. 1985 . Further studies may be required to directly assess the action of cGMP in vascular smooth muscle cells and glomerular mesangial cells.
However, there are some observations which weaken the hypothesis that cGMP mediates the action of ANP. One problem is that the threshold ANP concentrations to elicit a cGMP response so far have been reported to be in the range of 10 nM or above, whereas those to occupy ANP receptors or to elicit half-maximal smooth muscle relaxation are in the range of 1 nM or above (Ballermann and Brenner 1986 ; ). In the present study using 0.5 mM IBMX, however, we observed that threshold concentrations of AP III in increase cGMP levels were as low as 0.01 nM in VSM cells and 0.1 nM in GM cells. Although we do not know the exact reason for the different threshold levels of ANP to elicit a cGMP response, it may be probably attributable to differences in experimental conditions, materials for experiments (tissue homogenates, slices or cultured cells), cell culture conditions or the sensitivity of the assay of intracellular cGMP. Although used subcultured GM cells between the 12th and 20th passage to observe the stimulatory effect of ANP on cGMP synthesis, in our experience, such aged VSM or GM cells may possibly lose their properties in vivo.
In contrast to VSM or GM cells, the degree of cGMP accumulation was low and the threshold ANP concentration for cGMP rise was 10 nM in RPCT cells, suggesting that cGMP may not be involved in the physiological action of ANP in RPCT cells. It has been also reported that ANP increased cGMP levels in microdissected glomeruli but not in any segments (from the proximal convoluted tubule up to the outer mediullary collecting tubule of the rat and rabbit kidney (Chabardes et al. 1987 ). These results seem to be in contradiction with the autoradiographic binding atudies demonstrating that inner medullar (papilla) is one of the major bindidg site of ANP (Von Schroder et al. 1985 ; Chai et al. 1986 ; Koseki et al. 1986 ). In cultured bovine aortic endothelial cells and vascular smooth muscle cells, however, it has been recently suggested that there are at least two functionally distinct ANP binding sites ; one is the receptor coupled to, and the other is not coupled to the activation of guanylate cyclase and cGMP formation (Leitman and Murad 1986; Scarborough et al. 1986 ). If this is also the case in RPCT cells, it may at least partly explain the disparity between the present results and those obtained from the bindidg study. Although basal cAMP levels did not change in RPCT cells after exposure to APs in this study and in previous reports (Appel et al. 1986 ; Chabardes et al. 1987) , it may be of note that ANP recently has been reported to inhibit the basal and hormone-stimulated adenylate cyclase activity in isolated glomeruli, loops of Henle and collecting ducts (AnandSrivastava et al. 1986 ). Further studies may be required to elucidate the molecular mechanism of ANP action in collecting tubule cells.
Another problem which hampers the possible role of cGMP in ANP action is a dissociation between natriuresis and urinary cGMP excretion. In ANP-infused spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats, Marsh et al. (1985) have reported that both strains responded with a significant dose related natriuresis of approximately similar magnitude, while the urinary cGMP excretion increased dramatically in W.KY but only modestly, if at all, in SHR. However, it seems likely that there were signicant relations between urinary cGMP excretion and sodium excretion either in SHR or in WKY. It should be also of note that SHR had higher initial blood pressure levels and responded greater than WKY to the hypotensive effect of infused ANP, suggesting that natriuresis induced by ANP in both strains could be modified by several factors other than cGMP-related changes. In the present study, we confirmed the previous findings showing positive relationship between urinary cGMP excretion and urine flow or urinary sodium excretion in anesthetized rats during AP infusion (Hamet et al. 1984; Gerzer et al. 1985) . These results are in good accordance with the recent observations that vasodilatory action of ANP correlated well with venous plasma cGMP concentration during the continuous infusion of ANP in human (Fujita et al. 1987 ).
In conclusion, we have demonstrated that APs strikingly stimulated cGMP accumulation in cultured rat glomerular mesangial and vascular smooth muscle cells and there were positive relationships between urinary cGMP and urine flow or urinary sodium excretion in AP-infused rats. These results suggest that glomerular mesangial cells as well as vascular smooth muscle cells are the principal target sites for ANP action and further support the hypothesis that cGMP mediates the cellular action of ANP.
